Hubei Jumpcan Pharmaceutical Co., Ltd.
SHH: 600566.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Fei Cao
- Employees
- 5,230
- Headquarters
- Taixing, China
- IPO year
- 2001
- Market cap
- CN¥26.4B
- Website
- https://www.jumpcan.com
Loading 600566…
Loading profile data…Frequently asked questions about 600566
What does Hubei Jumpcan Pharmaceutical Co., Ltd. (600566.SS) do?
Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, and trading of Chinese traditional medicines, western medicines, daily use chemical based Chinese traditional medicines, and Chinese medicine health products in China. The company offers Chinese and western medicines in the areas of pediatrics, gynecology...
Where does 600566.SS trade?
Hubei Jumpcan Pharmaceutical Co., Ltd. (600566.SS) trades on the Shanghai Stock Exchange.
What sector is 600566.SS in?
Hubei Jumpcan Pharmaceutical Co., Ltd. (600566.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Hubei Jumpcan Pharmaceutical Co., Ltd.?
Fei Cao is the chief executive officer of Hubei Jumpcan Pharmaceutical Co., Ltd. (600566.SS).
Where is Hubei Jumpcan Pharmaceutical Co., Ltd. headquartered?
Hubei Jumpcan Pharmaceutical Co., Ltd. is headquartered in China.
Does 600566.SS pay a dividend?
Yes — Hubei Jumpcan Pharmaceutical Co., Ltd. (600566.SS) paid a trailing twelve-month dividend of CNY 2.09 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 600566.SS go public?
Hubei Jumpcan Pharmaceutical Co., Ltd. (600566.SS) completed its initial public offering in 2001.